ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Nashville, TN, USA:

Niraparib + Dostarlimab in BRCA Mutated Breast Cancer

This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...

Enrolling
Breast Cancer
Stage II Breast Cancer
Drug: Niraparib
Drug: Dostarlimab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 8 other locations

This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination ...

Active, not recruiting
Breast Cancer
Drug: Endocrine Therapy
Drug: Tamoxifen

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 10 other locations

This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 o...

Enrolling
Breast Cancer
Drug: Talazoparib

Phase 2

Mass General Brigham
Mass General Brigham

Nashville, Tennessee, United States and 6 other locations

A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of C...

Enrolling
Breast Cancer Stage IV
Breast Cancer
Drug: MBQ-167

Phase 1

MBQ Pharma

Nashville, Tennessee, United States and 3 other locations

therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...

Enrolling
Breast Cancer
Hormone Receptor Positive Breast Cancer
Drug: ADJUVANT ENDOCRINE THERAPY
Combination Product: Pertuzumab+TRASTUZUMAB

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 27 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Nashville, Tennessee, United States and 9 other locations

The purpose of this study is to assess safety and tolerability of AZD2014 when given in combination with Fulvestrant

Active, not recruiting
Advanced Metastatic Breast Cancer
Drug: AZD2014
Drug: Fulvestrant

Phase 1

AstraZeneca
AstraZeneca

Nashville, Tennessee, United States and 4 other locations

Status recently updated

to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...

Enrolling
Active, not recruiting
Locally Advanced Breast Cancer
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

SCRI Development Innovations

Nashville, Tennessee, United States and 10 other locations

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

Nashville, Tennessee, United States and 8 other locations

This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast...

Enrolling
Breast Cancer
Drug: Avelumab
Drug: Palbociclib

Phase 2

Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine

Nashville, Tennessee, United States and 6 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems